GB:GENE ETF Price & Analysis
GENE ETF Chart & Stats
1952.00 p
--
Market closed
1952.00 p
--
Day’s Range― - ―
52-Week Range1,714.92 p - 2,044.50 p
Previous Close1,952 p
VolumeN/A
Average Volume (3M)651.00
AUM80.12M
NAV26.51
Expense Ratio0.40%
Holdings Count102
Beta0.79
Inception DateDec 19, 2017
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume840
30 Day Avg. Volume651
AlphaN/A
ETF Overview
Global Gender Equality UCITS ETF Accum A USD
The Global Gender Equality UCITS ETF Accum A USD (Ticker: GB:GENE) is a pioneering investment vehicle that seeks to align your financial goals with a commitment to social progress. This exchange-traded fund (ETF) is distinctly categorized under Size and Style, with a focus on the Total Market, and it operates within the Broad-based niche of gender equality. By investing in companies that champion gender balance, the fund not only provides an opportunity for diversification across global markets but also supports corporations that demonstrate a strong commitment to gender parity in leadership and workforce representation. This ETF is designed for investors who are not only looking to achieve financial returns but also wish to contribute to societal change by endorsing corporate practices that promote gender equality. Its unique approach offers a dual benefit of capital growth potential and participation in a socially responsible investment strategy, making it an attractive choice for those who want their investments to reflect their values.
Global Gender Equality UCITS ETF Accum A USD (GENE) Fund Flow Chart
Global Gender Equality UCITS ETF Accum A USD (GENE) 1 year Net Flows: -45M
GENE ETF News
GENE ETF FAQ
What was GB:GENE’s price range in the past 12 months?
GB:GENE lowest ETF price was 1714.92 p and its highest was 2044.50 p in the past 12 months.
What is the AUM of GB:GENE?
As of Sep 09, 2026 The AUM of GB:GENE is 80.12M.
Is GB:GENE overvalued?
According to Wall Street analysts GB:GENE’s price is currently Undervalued.
Does GB:GENE pay dividends?
GB:GENE does not currently pay dividends.
How many shares outstanding does GB:GENE have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:GENE?
Currently, no hedge funds are holding shares in GB:GENE
GENE ETF Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Illumina
1.96%
Keysight Technologies Inc
1.73%
Merck & Company
1.68%
Standard Chartered
1.45%
Johnson & Johnson
1.42%
Biogen Inc.
1.40%
General Motors Company
1.36%
Alcoa Corporation
1.36%
Canadian Imperial Bank Of Commerce
1.33%
Principal Financial
1.32%
Total15.01%
See All Holdings









